XORTX Therapeutics Inc V.XRTX

Alternate Symbol(s): XRTX

Healthcare

XORTX Therapeutics Inc. is a Canada-based late-stage clinical pharmaceutical company. The Company develops therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD), as well as type 2 diabetic nephropathy (T2DN) and fatty liver disease. It is working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid. The Company has three product development programs: XRx-008, which is a program for the treatment of ADPKD; XRx-101, which is a program to treat acute kidney injury (AKI) associated with respiratory virus infection, AKI and associated health consequences, and XRx- 225, a program for the treatment of T2DN. The Company's XRx-008 program is designed for longer term stable chronic oral dosing of xanthine oxidase inhibitors.

TSXV:XRTX - Post by User

XORTX Therapeutics Inc > Scumbag CEO's on Ventures, Manipulate price to get Shrhldrs

<< Previous

Bullboard Posts

Next >>

Comment by SpaceLabson Jun 15, 2021 2:27pm

146 Views

Post# 33389551

RE:RE:RE:RE:RE:RE:RE:RE:RE:Scumbag CEO's on Ventures, Manipulate price to get Shrhldrs

They are developing what is most needed and only one company has it but not all that good.

XRX has it in dev stage but too slow in getting a partner to move it forward.
I hope BILL is the answer to this dilemma sharhldrs are facing at xrx.
Pathetic to see it trade this low unless they have nothing in pipe.

<< Previous

Bullboard Posts

Next >>

From now on, dynaCERT instead of Bitcoin or NVIDIA?